IngenioRx is taking a proactive approach to disease management and prevention. To help members manage type 2 diabetes and reduce their A1C (blood sugar) levels, we launched MealAdvisor, a six-month pilot using an app to monitor members’ behaviors, reward healthy choices, and encourage drug adherence. The pilot runs from March through August 2021. Its objective is to determine if members can reduce their A1C levels and improve medication adherence over time through consistent use of an app.
Research from the Centers for Disease Control and Prevention (CDC) reveals more than 34 million American adults have diabetes, and 88 million — approximately 1 in 3 — have prediabetes.1 Less than 50% of patients with diabetes know their A1C level or what their target level is.2 An A1C level is a key predictor for increased complications such as cardiovascular disease, nephropathy, and retinopathy.2 Studies show keeping a patient’s A1C level below 5.7% helps stave off diabetes.3
An American College of Cardiology study supports lifestyle modification for diabetes management: “Type 2 diabetes is a costly chronic illness that is increasing in prevalence and associated with significant health problems, including cardiovascular disease. Diabetes-related care accounts for more than $1 of every $5 spent on healthcare in the United States. Not surprisingly, average medical expenses are more than twice as high for a person with diabetes as they are for a person without diabetes.”4
Says Sasha Kuprion, Strategy Director for IngenioRx product development, “The philosophy behind the [MealAdvisor] program is that making small changes can add up to big results over time. We hope members can use this app to identify where they can make small changes in their routine to see improvements in their blood sugar levels, their weight, their overall health, and their overall sense of well-being.”